Faculty

Institution

Unit

Venue

Joanna-Grace M Manzano, MD, MPH, FACP

Associate Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hospitalist Medicine

Joanna-grace M Manzano, Md, Mph, Facp is currently serving as a Hospitalist Medicine Associate Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Joanna-Grace M Manzano, MD, MPH, FACP

The University of Texas MD Anderson Cancer Center

Associate Professor

You can click a keyword to filter the displayed items

oncology cancer care medicine outcomes research covid-19 cancer management immunotherapy health policy radiation oncology health services research health care critical care thoracic oncology hospital infections palliative medicine cellular therapy immune checkpoint inhibitors palliative care respiratory medicine health systems covid-19 pandemic surgical oncology internal medicine jama oncology comprehensive cancer center medical virology clinical immunology geriatrics infection control critical care clinic prognosis clinical infection patient management long covid hematological malignancies terminal illness malignant blood disorders cancer treatment breast oncology cancer patients thrombosis gastrointestinal surgery cell transplantation general internal medicine healthcare value quality improvement pulmonary diseases infectious respiratory disease respiratory infections surgical quality control acute kidney injury immunosuppression prognostic evaluation acute care bronchial neoplasm aging-associated diseases geriatric medicine vaccine trials disease transmission cytokines treatment plan evaluation patient-reported outcomes elderly patients gi cancer unplanned hospitalization cms target nontarget conditions migratory pulmonary infiltrates gi cancer hospitalizations readmission patterns intensive care unit stage iv cancer renal replacement therapy cytokine storms hospitalization characteristics interstitial lung abnormalities symptom management emergency medicine epidemiology survival analysis family medicine clinical epidemiology emergency nursing public health patient safety health planning chronic diseases health informatics primary care preventive healthcare palliative nursing health information science health sciences individualized medicine medical systems implementation research hospital medicine nursing surgical education international health preventive medicine cancer letter medical education personalized medicine clinical trials intensive care clinical nursing nursing science nurse practitioners medical ethics mortality

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Multi-Institutional Perspective on Tarlatamab Administration and Management of Crs/Icans. Lung Cancer (2025)

administrative sciencetarlatamab administrationstrategic managementmanagementgovernancebusinessinternal controls

Cytokine Storms in Covid-19, Hemophagocytic Lymphohistiocytosis, and Car-T Therapy. JAMA Network Open (2025)

cytokine stormsimmune responsescovid-19cellular therapyinfectious diseasesmedical virologyclinical immunologyimmunologycell transplantationimmunosuppression

Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers (2025)

hematologyimmunotherapy-related adverse eventsmedicinevaccine trialsoncologyradiation oncologyimmune checkpoint inhibitorsimmunotherapycancer managementcancer careonco-hospitalist medicine serviceclinical outcomesjama oncology

Risk Factors of Developing Multisystem Immunotherapy-Related Adverse Events Among Patients With Breast Cancer Treated With Immune Checkpoint Inhibitors.. Journal of Clinical Oncology (2025)

cancer immunotherapycellular therapyoncologyradiation oncologybreast oncologyrisk factorsimmune checkpoint inhibitorsimmunotherapycancer careimmunologycancer treatmentbreast cancer

Transitional Care Management for Cancer Patients: Extending General Models of Population Health Management to an Oncology Specific Population.. JCO Oncology Practice (2025)

transitional care managementpopulation health managementfamily medicinecancer patientsoncologyhealth systemshealth carecancer managementnursingcancer careterminal illnesssupportive care

1182 Multisystem Immunotherapy-Related Adverse Events Among Patients With Breast Cancer Treated With Immune Checkpoint Inhibitors. Regular and Young Investigator Award Abstracts (2024)

cellular therapyoncologyradiation oncologybreast oncologyimmune checkpoint inhibitorsimmunotherapycancer careimmunologycancer treatmentbreast cancer

1192 Immunotherapy Related Adverse Events and Clinical Outcomes in Adult Solid Tumor Cancer Patients on Immune Checkpoint Inhibitors Admitted to a Tertiary Medical Center Hospitalist Medicine Service. Regular and Young Investigator Award Abstracts (2024)

cellular therapyoncologyimmune checkpoint inhibitorsimmunotherapycancer careimmunology

Optimizing Inpatient Care for Lung Cancer Patients With Immune Checkpoint Inhibitor-Related Pneumonitis Using a Clinical Care Pathway Algorithm. Supportive Care in Cancer (2024)

lung cancermedicinemedical systemsoncologyhealth careprimary carepalliative medicinehospital infectionsinterstitial lung diseasecancer carethoracic oncologyhospital medicinerespiratory medicinenursinghealth policyjama oncologypalliative care

Treatment Patterns and Outcomes of High-Grade Immune Checkpoint Inhibitor-Related Pneumonitis in an Oncology Hospitalist Service. Supportive Care in Cancer (2024)

medicineoncologyimmune checkpoint inhibitorsimmunotherapycancer care

444 Unveiling Immune-Related Adverse Events (Iraes) and Symptom Burden in Melanoma Patients on Adjuvant Immune Checkpoint Inhibitors (Icis). Regular and Young Investigator Award Abstracts (2023)

Noha Abdel-WahabBilal AnoutiReham Abdel-WahabZaida GonzalesChristine A SpillsonGeorge P BaumSalah-Eddine BentebibelJoanna-Grace M ManzanoJennifer McQuadeIsabella GlitzaRodabe AmariaSapna PatelMichael K WongHussain TawbiMichael A DaviesSuhendan EkmekciogluDavid TweardyPadmanee SharmaSanjay SheteSusan PetersonCassian YeeMaria E Suarez-AlmazorAdi Diab

melanoma patientscancer immunotherapysymptomatic treatmentcancer immunosurveillancepharmacologymelanomaoncologycancer researchimmunotherapycancer careclinical immunologyclinical trialsimmunologyhealth sciencesmedicinal researchsymptom burdenexperimental therapeuticsclinical rheumatologyexperimental medicinepharmacotherapy

1
2
3
4
10 / page

Joanna-Grace M Manzano, MD, MPH, FACP

Associate Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hospitalist Medicine

Joanna-grace M Manzano, Md, Mph, Facp is currently serving as a Hospitalist Medicine Associate Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Joanna-Grace M Manzano, MD, MPH, FACP

The University of Texas MD Anderson Cancer Center

Associate Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Multi-Institutional Perspective on Tarlatamab Administration and Management of Crs/Icans. Lung Cancer (2025)

administrative sciencetarlatamab administrationstrategic managementmanagementgovernancebusinessinternal controls

Cytokine Storms in Covid-19, Hemophagocytic Lymphohistiocytosis, and Car-T Therapy. JAMA Network Open (2025)

cytokine stormsimmune responsescovid-19cellular therapyinfectious diseasesmedical virologyclinical immunologyimmunologycell transplantationimmunosuppression

Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers (2025)

Risk Factors of Developing Multisystem Immunotherapy-Related Adverse Events Among Patients With Breast Cancer Treated With Immune Checkpoint Inhibitors.. Journal of Clinical Oncology (2025)

cancer immunotherapycellular therapyoncologyradiation oncologybreast oncologyrisk factorsimmune checkpoint inhibitorsimmunotherapycancer careimmunologycancer treatmentbreast cancer

Transitional Care Management for Cancer Patients: Extending General Models of Population Health Management to an Oncology Specific Population.. JCO Oncology Practice (2025)

transitional care managementpopulation health managementfamily medicinecancer patientsoncologyhealth systemshealth carecancer managementnursingcancer careterminal illnesssupportive care

1182 Multisystem Immunotherapy-Related Adverse Events Among Patients With Breast Cancer Treated With Immune Checkpoint Inhibitors. Regular and Young Investigator Award Abstracts (2024)

cellular therapyoncologyradiation oncologybreast oncologyimmune checkpoint inhibitorsimmunotherapycancer careimmunologycancer treatmentbreast cancer

cellular therapyoncologyimmune checkpoint inhibitorsimmunotherapycancer careimmunology

Optimizing Inpatient Care for Lung Cancer Patients With Immune Checkpoint Inhibitor-Related Pneumonitis Using a Clinical Care Pathway Algorithm. Supportive Care in Cancer (2024)

Treatment Patterns and Outcomes of High-Grade Immune Checkpoint Inhibitor-Related Pneumonitis in an Oncology Hospitalist Service. Supportive Care in Cancer (2024)

medicineoncologyimmune checkpoint inhibitorsimmunotherapycancer care

444 Unveiling Immune-Related Adverse Events (Iraes) and Symptom Burden in Melanoma Patients on Adjuvant Immune Checkpoint Inhibitors (Icis). Regular and Young Investigator Award Abstracts (2023)

1
2
3
4
10 / page